Insulin inhibits HMG-CoA reductase, an enzyme that catalyzes the rate-limiting step in cholesterol synthesis, resulting in hypercholesterolemia (Ojo O. A. et al., 2020). This evidence concerns the gene INS and Hypercholesterolemia.